Total Payments
$11,820
2024 Payments
$1,267
Companies
48
Transactions
807
Medicare Patients
2,341
Medicare Billing
$251,602
Payment Breakdown by Category
Food & Beverage$11,775 (99.6%)
Education$44.69 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,775 | 803 | 99.6% |
| Education | $44.69 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,675 | 121 | $0 (2024) |
| ABBVIE INC. | $871.15 | 51 | $0 (2024) |
| PFIZER INC. | $789.78 | 62 | $0 (2023) |
| Novo Nordisk Inc | $788.78 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $738.35 | 49 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $736.81 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $727.72 | 52 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $601.17 | 42 | $0 (2024) |
| Amarin Pharma Inc. | $579.78 | 40 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $511.94 | 33 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,267 | 84 | ABBVIE INC. ($244.38) |
| 2023 | $1,737 | 102 | Amgen Inc. ($289.96) |
| 2022 | $1,721 | 118 | Amgen Inc. ($253.54) |
| 2021 | $1,973 | 131 | Amgen Inc. ($279.52) |
| 2020 | $1,377 | 94 | Amgen Inc. ($222.77) |
| 2019 | $820.67 | 60 | Amgen Inc. ($157.57) |
| 2018 | $1,231 | 97 | Amgen Inc. ($160.40) |
| 2017 | $1,694 | 121 | Boehringer Ingelheim Pharmaceuticals, Inc. ($270.37) |
All Payment Transactions
807 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ANTI-DIABETIC | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/18/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ANTI-DIABETIC | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: Bone Health | ||||||
| 10/30/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiology | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: UROLOGY | ||||||
| 10/03/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Endocrinology | ||||||
| 10/02/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.78 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTI-DIABETIC | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Inflammation | ||||||
| 09/10/2024 | Avvisto Therapeutics, LLC | CYCLOSET (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: ANTI-DIABETIC | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 400 | 848 | $96,476 | $67,137 |
| 2022 | 15 | 664 | 1,475 | $104,975 | $67,272 |
| 2021 | 16 | 662 | 1,332 | $103,890 | $68,813 |
| 2020 | 14 | 615 | 1,058 | $80,737 | $48,380 |
Total Patients
2,341
Total Services
4,713
Medicare Billing
$251,602
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 385 | $51,885 | $34,917 | 67.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 203 | $18,270 | $12,574 | 68.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 72 | 72 | $10,656 | $8,799 | 82.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 67 | $5,935 | $4,089 | 68.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 23 | 24 | $2,050 | $1,566 | 76.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,850 | $1,414 | 76.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 14 | $1,980 | $1,405 | 70.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 21 | $2,340 | $1,300 | 55.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 32 | $1,125 | $911.10 | 81.0% |
| 90471 | Administration of vaccine | Office | 2023 | 11 | 11 | $385.00 | $163.13 | 42.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 502 | $45,180 | $30,148 | 66.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $13,616 | $11,265 | 82.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 126 | $17,010 | $10,835 | 63.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 81 | $7,606 | $4,205 | 55.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 20 | $4,940 | $2,993 | 60.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 42 | 42 | $2,100 | $2,058 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 29 | 33 | $1,980 | $1,306 | 66.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 19 | 23 | $2,139 | $1,187 | 55.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 47 | 47 | $1,175 | $1,152 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 99 | 296 | $2,960 | $876.63 | 29.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 28 | 48 | $2,160 | $452.59 | 21.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 24 | 33 | $1,320 | $328.37 | 24.9% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2022 | 25 | 65 | $1,625 | $273.43 | 16.8% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 11 | 27 | $324.00 | $104.63 | 32.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 27 | 40 | $840.00 | $88.78 | 10.6% |
About Dr. Bart Olash, M.D
Dr. Bart Olash, M.D is a Internal Medicine healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1366559015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bart Olash, M.D has received a total of $11,820 in payments from pharmaceutical and medical device companies, with $1,267 received in 2024. These payments were reported across 807 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,775).
As a Medicare-enrolled provider, Olash has provided services to 2,341 Medicare beneficiaries, totaling 4,713 services with total Medicare billing of $251,602. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Louisville, KY
- Active Since 08/25/2006
- Last Updated 10/23/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1366559015
Products in Payments
- CYCLOSET (Drug) $662.13
- Vascepa (Drug) $579.78
- FARXIGA (Drug) $517.04
- ENTRESTO (Drug) $499.64
- EVENITY (Biological) $490.70
- TRELEGY ELLIPTA (Drug) $431.23
- ELIQUIS (Drug) $430.31
- NEXLETOL (Drug) $398.57
- Aimovig (Biological) $396.05
- Otezla (Drug) $383.97
- UBRELVY (Drug) $383.32
- XARELTO (Drug) $368.35
- Ozempic (Drug) $351.34
- VRAYLAR (Drug) $298.74
- GEMTESA (Drug) $294.12
- Kerendia (Drug) $239.46
- Prolia (Biological) $217.75
- CHANTIX (Drug) $216.68
- TRULICITY (Drug) $205.86
- LEQVIO (Drug) $180.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Louisville
Hisham Alrefai, Md, MD
Internal Medicine — Payments: $1.1M
Internal Medicine $1.1M
Dr. Matthew Cave, M.d, M.D
Internal Medicine — Payments: $373,716
Internal Medicine $373,716
Dr. Daniel Stewart, M.d, M.D
Internal Medicine — Payments: $284,815
Internal Medicine $284,815
Dr. Jaspreet Grewal, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $262,625
Internal Medicine $262,625
Mohamed Hegazi, Md, MD
Internal Medicine — Payments: $244,885
Internal Medicine $244,885
Dr. Dawn Caster, M.d, M.D
Internal Medicine — Payments: $158,400
Internal Medicine $158,400